TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

June 12, 2019

Conditions

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)

Interventions

DRUG

Clopidogrel

DRUG

Ticagrelor

Trial Locations (2)

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Hospital Clínic de Barcelona, Barcelona